Merck (XPAR:MRK) Interest Expense : €-1,063 Mil (TTM As of Dec. 2023)

View and export this data going back to 1946. Start your Free Trial

What is Merck Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Merck's interest expense for the three months ended in Dec. 2023 was € -284 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-1,063 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Merck's Operating Income for the three months ended in Dec. 2023 was € -1,571 Mil. Merck's Interest Expense for the three months ended in Dec. 2023 was € -284 Mil. Merck did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Merck Interest Expense Historical Data

The historical data trend for Merck's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Interest Expense Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-803.70

-683.08

-713.31

-908.13

-1,050.88

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-221.84	-226.03	-255.67	-297.03	-284.27

Merck Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,063 Mil.

Merck (XPAR:MRK) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Merck's Interest Expense for the three months ended in Dec. 2023 was €-284 Mil. Its Operating Income for the three months ended in Dec. 2023 was €-1,571 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was €30,887 Mil.

Merck's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Merck did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Merck (XPAR:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XPAR:MRK) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany 6MK:Germany 6MK:Germany 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.